Stock Research for ABSCF

ABSCF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ABSCF Stock Chart & Research Data

The ABSCF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ABSCF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ABSCF Due diligence Resources & Stock Charts

The ABSCF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ABSCF Detailed Price Forecast - CNN Money CNN View ABSCF Detailed Summary - Google Finance
Yahoo View ABSCF Detailed Summary - Yahoo! Finance Zacks View ABSCF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ABSCF Trends & Analysis - Trade-Ideas Barrons View ABSCF Major Holders - Barrons
NASDAQ View ABSCF Call Transcripts - NASDAQ Seeking View ABSCF Breaking News & Analysis - Seeking Alpha
Spotlight View ABSCF Annual Report - CompanySpotlight.com OTC Report View ABSCF OTC Short Report - OTCShortReport.com
TradeKing View ABSCF Fundamentals - TradeKing Charts View ABSCF SEC Filings - Bar Chart
WSJ View Historical Prices for ABSCF - The WSJ Morningstar View Performance/Total Return for ABSCF - Morningstar
MarketWatch View the Analyst Estimates for ABSCF - MarketWatch CNBC View the Earnings History for ABSCF - CNBC
StockMarketWatch View the ABSCF Earnings - StockMarketWatch MacroAxis View ABSCF Buy or Sell Recommendations - MacroAxis
Bullish View the ABSCF Bullish Patterns - American Bulls Short Pains View ABSCF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ABSCF Stock Mentions - StockTwits PennyStocks View ABSCF Stock Mentions - PennyStockTweets
Twitter View ABSCF Stock Mentions - Twitter Invest Hub View ABSCF Investment Forum News - Investor Hub
Yahoo View ABSCF Stock Mentions - Yahoo! Message Board Seeking Alpha View ABSCF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ABSCF - SECform4.com Insider Cow View Insider Transactions for ABSCF - Insider Cow
CNBC View ABSCF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ABSCF - OTC Markets
Yahoo View Insider Transactions for ABSCF - Yahoo! Finance NASDAQ View Institutional Holdings for ABSCF - NASDAQ


Stock Charts

FinViz View ABSCF Stock Insight & Charts - FinViz.com StockCharts View ABSCF Investment Charts - StockCharts.com
BarChart View ABSCF Stock Overview & Charts - BarChart Trading View View ABSCF User Generated Charts - Trading View




Latest Financial News for ABSCF


AB Science announces that the masitinib phase 3 study in Alzheimer's disease has completed patient recruitment
Posted on Monday October 22, 2018

FR0010557264 - AB), a pharmaceutical company specialized in the research, development and marketing of protein kinase inhibitors (PKIs), announces today that the masitinib phase 3 study in Alzheimer's disease has completed patient recruitment.


AB Science announces the publication of a previously unknown mechanism linked to the progression of ALS and that further reinforces the rationale why masitinib might be protective in ALS
Posted on Sunday October 07, 2018

FR0010557264 - AB), a pharmaceutical company specialized in the research, development and marketing of protein kinase inhibitors (PKIs), announces the publication by an international team of researchers of a previously unknown mechanism linked to the progression of Amyotrophic Lateral Sclerosis (ALS) and that further reinforces the rationale why masitinib might be protective in ALS. The publication, led by researchers from the Institut Pasteur de Montevideo, the University of Alabama at Birmingham (UAB), the Oregon State University (OSU) and the IMAGINE Institute of Paris, is entitled, 'Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS'.


AB Science today reports its revenues for the first half of 2018
Posted on Sunday September 30, 2018

Paris, October 1 st 2018, 8.30 am. Net loss of 11.1 M€ in the first half of 2018. Cash position of 21.1 M€ as of 30 June 2018, plus 6.6 M€ of 2017 tax credit reimbursed by the Public Finance Department ...


What Are The Drivers Of AB Science SA’s (EPA:AB) Risks?
Posted on Friday September 14, 2018

Anyone researching AB Science SA (EPA:AB) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance theory.Read More...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.